Pathfinder Cell Therapy, Inc. (PFND)

Pathfinder Cell Therapy Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2014	FY 2013	FY 2012	FY 2011	FY 2010
Period Ending	Sep 30, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012	Dec 31, 2011	Dec 31, 2010
Cash & Equivalents	0	0.03	0.04	0.01	0.2	0.02
Cash & Short-Term Investments	0	0.03	0.04	0.01	0.2	0.02
Cash Growth	-82.61%	-40.91%	388.89%	-95.41%	1206.67%	16.64%
Receivables	-	-	-	0.03	0.05	-
Inventory	-	-	-	0.03	0.05	-
Prepaid Expenses	0.01	0.05	0.08	0.08	0.12	0.01
Total Current Assets	0.01	0.07	0.12	0.15	0.42	0.03
Property, Plant & Equipment	-	-	-	-	0	-
Other Intangible Assets	0.03	0.03	0.04	0.21	0.23	0.16
Total Assets	0.04	0.11	0.16	0.36	0.64	0.19
Accounts Payable	0.33	0.23	0.19	0.08	0.24	0.24
Accrued Expenses	1.03	0.84	0.53	0.63	0.56	0.02
Short-Term Debt	5.41	4.98	3.99	2.25	0.32	0.98
Other Current Liabilities	-	-	-	0.02	0.01	0
Total Current Liabilities	6.77	6.05	4.71	2.98	1.13	1.24
Other Long-Term Liabilities	-	-	-	0.23	0.23	0.08
Total Liabilities	6.77	6.05	4.71	3.21	1.35	1.32
Common Stock	0.67	0.67	0.67	0.67	0.67	0.46
Additional Paid-In Capital	11.83	11.83	11.83	11.82	11.81	0.29
Retained Earnings	-19.23	-18.44	-17.05	-15.34	-13.19	-1.87
Shareholders' Equity	-6.73	-5.94	-4.55	-2.85	-0.71	-1.13
Total Liabilities & Equity	0.04	0.11	0.16	0.36	0.64	0.19
Total Debt	5.41	4.98	3.99	2.25	0.32	0.98
Net Cash (Debt)	-5.41	-4.96	-3.95	-2.25	-0.12	-0.97
Net Cash Per Share	-0.01	-0.01	-0.01	-0.00	-0.00	-0.00
Filing Date Shares Outstanding	667.16	667.16	667.16	667.16	667.16	458
Total Common Shares Outstanding	667.16	667.16	667.16	667.16	667.16	458
Working Capital	-6.76	-5.98	-4.59	-2.83	-0.71	-1.21
Book Value Per Share	-0.01	-0.01	-0.01	-0.00	-0.00	-0.00
Tangible Book Value	-6.76	-5.98	-4.59	-3.06	-0.93	-1.29
Tangible Book Value Per Share	-0.01	-0.01	-0.01	-0.00	-0.00	-0.00

Source: S&P Global Market Intelligence. Standard template. Financial Sources.